HB Luiting
Papers
1
Total Citations
8
H-Index
1
About
Dr. HB Luiting is a prominent urologic oncologist whose research centers on optimizing surgical outcomes for bladder cancer, particularly through comparative effectiveness studies of robot-assisted versus open radical cystectomy. His most cited work, a 2021 study examining intermediate-term survival outcomes in the Netherlands, provides critical real-world evidence that robot-assisted radical cystectomy (RARC) achieves non-inferior oncological results compared to open surgery for muscle-invasive and high-risk non-muscle invasive bladder cancer. This landmark analysis, drawing from national registry data, has garnered 8 citations and directly informs clinical decision-making by demonstrating that minimally invasive approaches do not compromise survival while potentially reducing recovery times. Dr. Luiting’s contributions extend to advancing surgical quality standards and patient selection criteria, with his work frequently cited in guidelines and meta-analyses. By bridging the gap between randomized trial findings and population-level outcomes, he has helped validate RARC as a viable standard-of-care alternative. His research continues to shape the evolution of bladder cancer surgery, emphasizing evidence-based practice and long-term patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1